Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mycobacterium tuberculosis | 29 | 2024 | 1914 | 5.700 |
Why?
|
Antitubercular Agents | 16 | 2024 | 1375 | 3.800 |
Why?
|
Pseudomonas aeruginosa | 13 | 2024 | 1272 | 3.620 |
Why?
|
Host-Pathogen Interactions | 14 | 2024 | 1454 | 2.790 |
Why?
|
Drug Resistance, Bacterial | 11 | 2021 | 1049 | 2.780 |
Why?
|
Bacterial Proteins | 26 | 2024 | 3842 | 2.720 |
Why?
|
Anti-Bacterial Agents | 27 | 2024 | 7403 | 2.420 |
Why?
|
Bacteria | 17 | 2024 | 2192 | 2.390 |
Why?
|
Microbial Sensitivity Tests | 19 | 2024 | 1936 | 2.120 |
Why?
|
Klebsiella pneumoniae | 5 | 2022 | 249 | 1.860 |
Why?
|
Small Molecule Libraries | 7 | 2024 | 733 | 1.860 |
Why?
|
Genes, Essential | 5 | 2024 | 185 | 1.770 |
Why?
|
RNA, Bacterial | 4 | 2019 | 393 | 1.760 |
Why?
|
Carbapenems | 5 | 2021 | 123 | 1.670 |
Why?
|
Virulence | 11 | 2024 | 1299 | 1.590 |
Why?
|
Gene Expression Regulation, Bacterial | 12 | 2024 | 1131 | 1.560 |
Why?
|
Coumarins | 3 | 2018 | 118 | 1.460 |
Why?
|
Bacterial Infections | 8 | 2019 | 1389 | 1.430 |
Why?
|
Tuberculosis | 10 | 2023 | 2015 | 1.410 |
Why?
|
Drug Discovery | 5 | 2024 | 1051 | 1.330 |
Why?
|
beta-Lactam Resistance | 3 | 2020 | 73 | 1.310 |
Why?
|
beta-Lactams | 3 | 2015 | 155 | 1.220 |
Why?
|
Pseudomonas Infections | 5 | 2021 | 621 | 1.210 |
Why?
|
Genome, Bacterial | 9 | 2023 | 783 | 1.130 |
Why?
|
Antigens, Bacterial | 4 | 2017 | 1141 | 1.020 |
Why?
|
Gene Expression Profiling | 11 | 2024 | 9417 | 0.970 |
Why?
|
Bacterial Outer Membrane Proteins | 3 | 2022 | 404 | 0.970 |
Why?
|
Macrophages | 10 | 2024 | 5758 | 0.950 |
Why?
|
Bacterial Toxins | 4 | 2013 | 925 | 0.940 |
Why?
|
Receptors, Kainic Acid | 1 | 2024 | 91 | 0.920 |
Why?
|
Zebrafish | 8 | 2024 | 3005 | 0.900 |
Why?
|
Bacterial Physiological Phenomena | 4 | 2019 | 119 | 0.890 |
Why?
|
Kynurenine | 1 | 2024 | 141 | 0.880 |
Why?
|
Evolution, Molecular | 3 | 2021 | 1880 | 0.860 |
Why?
|
Carbon | 4 | 2024 | 665 | 0.810 |
Why?
|
Tryptophan Synthase | 2 | 2021 | 9 | 0.780 |
Why?
|
Drug Resistance, Multiple, Bacterial | 3 | 2021 | 585 | 0.780 |
Why?
|
Nucleic Acid Hybridization | 2 | 2019 | 1301 | 0.720 |
Why?
|
Sequence Analysis, RNA | 7 | 2023 | 2013 | 0.720 |
Why?
|
High-Throughput Screening Assays | 5 | 2021 | 933 | 0.700 |
Why?
|
DNA Gyrase | 2 | 2019 | 85 | 0.680 |
Why?
|
Virulence Factors | 6 | 2024 | 513 | 0.660 |
Why?
|
Mycobacterium smegmatis | 3 | 2017 | 126 | 0.660 |
Why?
|
Adaptation, Biological | 1 | 2020 | 147 | 0.650 |
Why?
|
Anti-Infective Agents | 3 | 2023 | 983 | 0.650 |
Why?
|
Colistin | 1 | 2019 | 44 | 0.650 |
Why?
|
Embryo, Nonmammalian | 4 | 2024 | 905 | 0.620 |
Why?
|
Porins | 1 | 2018 | 78 | 0.620 |
Why?
|
Bacillus anthracis | 3 | 2013 | 118 | 0.610 |
Why?
|
Mycolic Acids | 2 | 2019 | 54 | 0.600 |
Why?
|
Host-Parasite Interactions | 1 | 2019 | 300 | 0.580 |
Why?
|
Cell Death | 2 | 2013 | 1677 | 0.580 |
Why?
|
Peptides, Cyclic | 1 | 2019 | 392 | 0.570 |
Why?
|
Salmonella typhimurium | 2 | 2017 | 347 | 0.550 |
Why?
|
Ofloxacin | 1 | 2016 | 66 | 0.550 |
Why?
|
Ethionamide | 1 | 2016 | 11 | 0.540 |
Why?
|
Azetidines | 1 | 2017 | 142 | 0.530 |
Why?
|
Structure-Activity Relationship | 9 | 2024 | 3074 | 0.520 |
Why?
|
Salmonella | 1 | 2016 | 125 | 0.520 |
Why?
|
Phagosomes | 1 | 2017 | 199 | 0.520 |
Why?
|
Systems Biology | 1 | 2019 | 481 | 0.510 |
Why?
|
Cell Wall | 4 | 2022 | 420 | 0.510 |
Why?
|
Tryptophan | 3 | 2024 | 482 | 0.500 |
Why?
|
Vibrio cholerae | 4 | 2007 | 793 | 0.500 |
Why?
|
Biofilms | 3 | 2009 | 626 | 0.490 |
Why?
|
Mixed Function Oxygenases | 1 | 2016 | 265 | 0.490 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 1033 | 0.480 |
Why?
|
Penicillin-Binding Proteins | 1 | 2015 | 149 | 0.480 |
Why?
|
Viruses | 1 | 2018 | 374 | 0.470 |
Why?
|
Gram-Negative Bacteria | 4 | 2022 | 271 | 0.460 |
Why?
|
Semicarbazones | 1 | 2013 | 4 | 0.460 |
Why?
|
Adaptation, Physiological | 1 | 2021 | 1300 | 0.460 |
Why?
|
Endosomes | 2 | 2013 | 522 | 0.450 |
Why?
|
Oxidoreductases | 1 | 2016 | 412 | 0.450 |
Why?
|
Chaperonin Containing TCP-1 | 1 | 2013 | 8 | 0.440 |
Why?
|
Gene Deletion | 2 | 2019 | 2659 | 0.440 |
Why?
|
Ribosomes | 1 | 2017 | 500 | 0.440 |
Why?
|
Animals | 51 | 2024 | 168202 | 0.420 |
Why?
|
Bile Acids and Salts | 2 | 2006 | 393 | 0.420 |
Why?
|
DNA, Bacterial | 4 | 2023 | 1471 | 0.410 |
Why?
|
eIF-2 Kinase | 1 | 2013 | 145 | 0.410 |
Why?
|
Thrombin | 8 | 1992 | 592 | 0.400 |
Why?
|
DNA Transposable Elements | 3 | 2022 | 754 | 0.380 |
Why?
|
Mice | 23 | 2024 | 81368 | 0.380 |
Why?
|
Cytosol | 2 | 2013 | 886 | 0.360 |
Why?
|
Drug Design | 3 | 2018 | 1045 | 0.360 |
Why?
|
beta-Lactamases | 4 | 2018 | 304 | 0.360 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2012 | 412 | 0.360 |
Why?
|
Urine | 1 | 2012 | 362 | 0.360 |
Why?
|
Phosphotransferases | 1 | 2011 | 303 | 0.350 |
Why?
|
Communicable Diseases | 1 | 2018 | 871 | 0.340 |
Why?
|
Virus Internalization | 1 | 2013 | 497 | 0.340 |
Why?
|
Mutagenesis, Insertional | 3 | 2022 | 656 | 0.340 |
Why?
|
Escherichia coli | 7 | 2021 | 4210 | 0.320 |
Why?
|
Mutation | 8 | 2019 | 30015 | 0.310 |
Why?
|
Butyrates | 2 | 2007 | 169 | 0.300 |
Why?
|
Naphthalenes | 2 | 2007 | 198 | 0.300 |
Why?
|
Klebsiella Infections | 2 | 2020 | 144 | 0.300 |
Why?
|
Substrate Specificity | 3 | 2021 | 1790 | 0.290 |
Why?
|
Phylogeny | 4 | 2020 | 2805 | 0.290 |
Why?
|
Receptors, Cell Surface | 9 | 1992 | 2802 | 0.270 |
Why?
|
Mice, Inbred BALB C | 4 | 2020 | 6188 | 0.270 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1169 | 0.270 |
Why?
|
Humans | 73 | 2024 | 760740 | 0.270 |
Why?
|
Molecular Structure | 5 | 2024 | 1878 | 0.260 |
Why?
|
Cholera Toxin | 2 | 2005 | 559 | 0.260 |
Why?
|
Reactive Oxygen Species | 3 | 2024 | 2137 | 0.250 |
Why?
|
Alkanes | 2 | 1996 | 41 | 0.250 |
Why?
|
Antibodies, Neutralizing | 4 | 2023 | 1936 | 0.250 |
Why?
|
Fibroblast Growth Factor 2 | 4 | 2000 | 592 | 0.250 |
Why?
|
Crystallography, X-Ray | 4 | 2021 | 1989 | 0.250 |
Why?
|
Drug Delivery Systems | 4 | 2019 | 2222 | 0.250 |
Why?
|
Oxyquinoline | 1 | 2024 | 16 | 0.240 |
Why?
|
Protein Kinases | 2 | 2011 | 1606 | 0.240 |
Why?
|
Cell Line | 11 | 2017 | 15577 | 0.240 |
Why?
|
RNA, Messenger | 2 | 2019 | 12759 | 0.240 |
Why?
|
Gene Library | 3 | 2017 | 1055 | 0.240 |
Why?
|
Urinary Tract Infections | 2 | 2021 | 802 | 0.230 |
Why?
|
Cell Membrane | 2 | 2024 | 3680 | 0.230 |
Why?
|
Disease Models, Animal | 7 | 2018 | 18220 | 0.230 |
Why?
|
RNA, Viral | 4 | 2021 | 2838 | 0.230 |
Why?
|
Acinetobacter baumannii | 2 | 2022 | 117 | 0.230 |
Why?
|
Antibodies, Viral | 4 | 2023 | 3149 | 0.220 |
Why?
|
Carbamates | 2 | 1996 | 191 | 0.220 |
Why?
|
Receptors, Thrombin | 10 | 1992 | 130 | 0.220 |
Why?
|
Lipopolysaccharides | 3 | 2022 | 2202 | 0.220 |
Why?
|
Pyocins | 1 | 2023 | 4 | 0.220 |
Why?
|
Quorum Sensing | 3 | 2009 | 137 | 0.210 |
Why?
|
Folic Acid | 2 | 2021 | 1323 | 0.210 |
Why?
|
Lactones | 2 | 1996 | 316 | 0.210 |
Why?
|
Cell-Free System | 1 | 2023 | 339 | 0.210 |
Why?
|
RNA | 3 | 2012 | 2713 | 0.210 |
Why?
|
Single-Cell Analysis | 4 | 2023 | 2447 | 0.200 |
Why?
|
Genes, Bacterial | 2 | 2022 | 1073 | 0.200 |
Why?
|
Molecular Biology | 1 | 2006 | 575 | 0.200 |
Why?
|
Microfluidic Analytical Techniques | 2 | 2020 | 799 | 0.200 |
Why?
|
Copper | 1 | 2024 | 367 | 0.200 |
Why?
|
Oxidative Stress | 1 | 2013 | 3115 | 0.190 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2018 | 1333 | 0.190 |
Why?
|
Drug Resistance, Multiple | 1 | 2022 | 255 | 0.190 |
Why?
|
Lipase | 1 | 2024 | 324 | 0.190 |
Why?
|
Models, Biological | 4 | 2013 | 9461 | 0.190 |
Why?
|
Pyridoxal Phosphate | 1 | 2021 | 121 | 0.190 |
Why?
|
Neutralization Tests | 1 | 2023 | 725 | 0.180 |
Why?
|
Cell Cycle | 4 | 2013 | 2929 | 0.180 |
Why?
|
Disease Outbreaks | 3 | 2017 | 1748 | 0.180 |
Why?
|
Intracellular Space | 1 | 2021 | 197 | 0.170 |
Why?
|
Genetic Fitness | 1 | 2021 | 115 | 0.170 |
Why?
|
Platelet Activation | 3 | 1992 | 646 | 0.170 |
Why?
|
Allosteric Regulation | 2 | 2021 | 427 | 0.170 |
Why?
|
Microbial Viability | 1 | 2021 | 236 | 0.170 |
Why?
|
Chlamydia trachomatis | 1 | 2021 | 239 | 0.170 |
Why?
|
Nasopharynx | 1 | 2022 | 400 | 0.160 |
Why?
|
Intestine, Small | 1 | 2005 | 1207 | 0.160 |
Why?
|
Plasmids | 2 | 2024 | 2265 | 0.160 |
Why?
|
Blood Donors | 1 | 2021 | 345 | 0.160 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2019 | 94 | 0.160 |
Why?
|
Bacterial Capsules | 1 | 2020 | 243 | 0.160 |
Why?
|
Drug Synergism | 2 | 2021 | 1756 | 0.160 |
Why?
|
Mice, Inbred C3H | 1 | 2020 | 913 | 0.160 |
Why?
|
Phenotype | 4 | 2019 | 16572 | 0.160 |
Why?
|
Immunity, Humoral | 1 | 2023 | 600 | 0.160 |
Why?
|
Pericardium | 3 | 1999 | 664 | 0.150 |
Why?
|
Cells, Cultured | 3 | 2021 | 18937 | 0.150 |
Why?
|
Escherichia coli Infections | 2 | 2012 | 518 | 0.150 |
Why?
|
Cell Membrane Permeability | 3 | 2021 | 574 | 0.150 |
Why?
|
Vancomycin | 1 | 2021 | 503 | 0.150 |
Why?
|
Transcription Factors | 5 | 2019 | 12116 | 0.150 |
Why?
|
Bacteriolysis | 1 | 2017 | 50 | 0.150 |
Why?
|
Protein Subunits | 1 | 2021 | 942 | 0.150 |
Why?
|
Drug Tolerance | 1 | 2019 | 367 | 0.150 |
Why?
|
Green Fluorescent Proteins | 3 | 2012 | 2063 | 0.140 |
Why?
|
Fimbriae, Bacterial | 2 | 2009 | 138 | 0.140 |
Why?
|
Chimera | 1 | 2018 | 453 | 0.140 |
Why?
|
Mycobacterium | 1 | 2019 | 251 | 0.140 |
Why?
|
Drug Interactions | 1 | 2022 | 1415 | 0.140 |
Why?
|
Electrochemical Techniques | 1 | 2017 | 93 | 0.140 |
Why?
|
Bacterial Adhesion | 2 | 2009 | 306 | 0.140 |
Why?
|
R Factors | 1 | 2017 | 35 | 0.140 |
Why?
|
Metabolic Networks and Pathways | 2 | 2012 | 789 | 0.140 |
Why?
|
Factor VIIa | 1 | 1998 | 103 | 0.140 |
Why?
|
Tuberculosis, Multidrug-Resistant | 2 | 2016 | 934 | 0.140 |
Why?
|
Biosynthetic Pathways | 1 | 2018 | 135 | 0.140 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6305 | 0.140 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2022 | 3634 | 0.140 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 22117 | 0.140 |
Why?
|
Naphthalimides | 2 | 2007 | 22 | 0.140 |
Why?
|
Binding Sites | 5 | 2021 | 6051 | 0.140 |
Why?
|
Genetic Testing | 1 | 2009 | 3533 | 0.140 |
Why?
|
Protein Transport | 2 | 2013 | 1966 | 0.130 |
Why?
|
Sepsis | 2 | 2021 | 2585 | 0.130 |
Why?
|
Ribonucleases | 1 | 2017 | 277 | 0.130 |
Why?
|
Clone Cells | 2 | 2017 | 1657 | 0.130 |
Why?
|
Drug Resistance, Microbial | 1 | 2019 | 825 | 0.130 |
Why?
|
Fluorescent Dyes | 1 | 2024 | 1901 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2024 | 10754 | 0.130 |
Why?
|
Thromboplastin | 1 | 1998 | 286 | 0.130 |
Why?
|
Catalytic Domain | 2 | 2021 | 704 | 0.130 |
Why?
|
Fatty Acids | 1 | 2024 | 1808 | 0.130 |
Why?
|
Genomics | 3 | 2022 | 5822 | 0.130 |
Why?
|
Ribotyping | 1 | 2015 | 35 | 0.130 |
Why?
|
Neovascularization, Physiologic | 2 | 2000 | 1349 | 0.130 |
Why?
|
Bone Marrow Cells | 3 | 2020 | 2409 | 0.130 |
Why?
|
Limit of Detection | 1 | 2016 | 273 | 0.130 |
Why?
|
Enterobacteriaceae | 1 | 2017 | 161 | 0.130 |
Why?
|
Public-Private Sector Partnerships | 1 | 2016 | 123 | 0.130 |
Why?
|
Phosphatidylinositols | 3 | 1992 | 282 | 0.120 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2015 | 221 | 0.120 |
Why?
|
Transcription, Genetic | 3 | 2024 | 7583 | 0.120 |
Why?
|
Amino Acid Sequence | 13 | 2023 | 13442 | 0.120 |
Why?
|
Dengue Virus | 1 | 2017 | 201 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2021 | 4569 | 0.120 |
Why?
|
Biological Products | 2 | 2011 | 912 | 0.120 |
Why?
|
Clavulanic Acid | 1 | 2014 | 19 | 0.120 |
Why?
|
Enterobacteriaceae Infections | 1 | 2017 | 188 | 0.120 |
Why?
|
Myocardial Ischemia | 3 | 2000 | 2110 | 0.120 |
Why?
|
Cloning, Molecular | 9 | 2021 | 4172 | 0.120 |
Why?
|
Platelet Membrane Glycoproteins | 2 | 1992 | 284 | 0.120 |
Why?
|
RNA, Ribosomal | 1 | 2015 | 227 | 0.120 |
Why?
|
Salmonella Infections | 1 | 2015 | 172 | 0.110 |
Why?
|
Virus Diseases | 1 | 2020 | 718 | 0.110 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1034 | 0.110 |
Why?
|
Pneumonia, Bacterial | 1 | 2016 | 315 | 0.110 |
Why?
|
Drug Combinations | 1 | 2019 | 2048 | 0.110 |
Why?
|
Enteropeptidase | 1 | 1992 | 10 | 0.110 |
Why?
|
Virus Replication | 1 | 2021 | 2427 | 0.110 |
Why?
|
Quinolines | 1 | 2018 | 764 | 0.110 |
Why?
|
Diketopiperazines | 1 | 2012 | 24 | 0.100 |
Why?
|
Organoselenium Compounds | 1 | 2012 | 21 | 0.100 |
Why?
|
Embryo, Mammalian | 1 | 2018 | 1670 | 0.100 |
Why?
|
Influenza, Human | 2 | 2022 | 1521 | 0.100 |
Why?
|
Thiourea | 1 | 2012 | 68 | 0.100 |
Why?
|
Polyenes | 1 | 1992 | 68 | 0.100 |
Why?
|
Clofazimine | 1 | 2012 | 41 | 0.100 |
Why?
|
Caspase 1 | 1 | 2013 | 226 | 0.100 |
Why?
|
Molecular Conformation | 1 | 2013 | 544 | 0.100 |
Why?
|
Coronary Vessels | 3 | 2000 | 3095 | 0.100 |
Why?
|
Proteome | 2 | 2024 | 1857 | 0.100 |
Why?
|
Selection, Genetic | 1 | 2016 | 868 | 0.100 |
Why?
|
Tacrolimus | 2 | 1993 | 733 | 0.100 |
Why?
|
Blood Coagulation | 1 | 1998 | 1154 | 0.100 |
Why?
|
Interferon Type I | 1 | 2015 | 557 | 0.090 |
Why?
|
DNA, Viral | 1 | 2018 | 2194 | 0.090 |
Why?
|
Biochemistry | 1 | 2012 | 114 | 0.090 |
Why?
|
Drugs, Chinese Herbal | 1 | 2013 | 144 | 0.090 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2012 | 274 | 0.090 |
Why?
|
Glycerol | 1 | 2012 | 275 | 0.090 |
Why?
|
Myocardium | 2 | 2021 | 4725 | 0.090 |
Why?
|
Mitosis | 1 | 1996 | 1187 | 0.090 |
Why?
|
Gene Duplication | 1 | 2012 | 314 | 0.090 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2015 | 432 | 0.090 |
Why?
|
Staphylococcus aureus | 1 | 2019 | 1457 | 0.090 |
Why?
|
Herpesvirus 2, Human | 1 | 2012 | 191 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20077 | 0.090 |
Why?
|
Uropathogenic Escherichia coli | 1 | 2009 | 6 | 0.090 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2013 | 424 | 0.090 |
Why?
|
Microtubules | 1 | 1996 | 1073 | 0.090 |
Why?
|
Models, Chemical | 1 | 2012 | 611 | 0.090 |
Why?
|
Peptide Hydrolases | 1 | 2013 | 624 | 0.090 |
Why?
|
Base Sequence | 6 | 2015 | 12420 | 0.090 |
Why?
|
Gene Transfer, Horizontal | 1 | 2010 | 144 | 0.080 |
Why?
|
Fungi | 1 | 2012 | 338 | 0.080 |
Why?
|
Pandemics | 4 | 2022 | 8652 | 0.080 |
Why?
|
Hematopoiesis | 1 | 2018 | 2049 | 0.080 |
Why?
|
Drosophila melanogaster | 1 | 2018 | 1712 | 0.080 |
Why?
|
Caenorhabditis elegans | 1 | 2018 | 1452 | 0.080 |
Why?
|
Endocytosis | 1 | 2013 | 955 | 0.080 |
Why?
|
Food | 1 | 2013 | 768 | 0.080 |
Why?
|
Paclitaxel | 1 | 1996 | 1730 | 0.080 |
Why?
|
Cyclic AMP | 1 | 1992 | 1463 | 0.080 |
Why?
|
Gram-Positive Bacteria | 1 | 2009 | 176 | 0.080 |
Why?
|
Promoter Regions, Genetic | 3 | 2011 | 5780 | 0.080 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2013 | 2495 | 0.080 |
Why?
|
Bacteremia | 1 | 2015 | 977 | 0.080 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1213 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 1 | 2024 | 5672 | 0.070 |
Why?
|
Molecular Sequence Data | 11 | 1992 | 17630 | 0.070 |
Why?
|
Mutagenesis | 3 | 2010 | 1230 | 0.070 |
Why?
|
Species Specificity | 1 | 2012 | 2410 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2812 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2021 | 4745 | 0.070 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9526 | 0.070 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 795 | 0.070 |
Why?
|
RNA Interference | 2 | 2013 | 2829 | 0.070 |
Why?
|
Ecosystem | 1 | 2011 | 487 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2018 | 2878 | 0.070 |
Why?
|
Genetic Techniques | 1 | 2009 | 428 | 0.070 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2013 | 1320 | 0.070 |
Why?
|
Leukocytes, Mononuclear | 1 | 2013 | 1834 | 0.070 |
Why?
|
Herpesvirus 1, Human | 1 | 2012 | 739 | 0.070 |
Why?
|
Kidney | 2 | 2021 | 7044 | 0.070 |
Why?
|
Biomedical Research | 2 | 2019 | 3426 | 0.070 |
Why?
|
Protein Conformation | 2 | 2013 | 3965 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3798 | 0.060 |
Why?
|
HeLa Cells | 1 | 2012 | 3088 | 0.060 |
Why?
|
Blotting, Western | 1 | 2013 | 5034 | 0.060 |
Why?
|
Pyrones | 2 | 1996 | 35 | 0.060 |
Why?
|
Liver | 1 | 2021 | 7512 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 2013 | 1797 | 0.060 |
Why?
|
Genotype | 1 | 2019 | 12977 | 0.060 |
Why?
|
Myeloid Cells | 2 | 2021 | 823 | 0.060 |
Why?
|
Sequence Alignment | 2 | 2021 | 2178 | 0.060 |
Why?
|
Models, Statistical | 1 | 2019 | 5074 | 0.060 |
Why?
|
Immunosuppressive Agents | 2 | 1994 | 4172 | 0.060 |
Why?
|
RNA, Small Interfering | 2 | 2011 | 3419 | 0.060 |
Why?
|
Signal Transduction | 6 | 2014 | 23415 | 0.060 |
Why?
|
Ethyl Ethers | 1 | 2023 | 20 | 0.060 |
Why?
|
Oxygen | 2 | 2013 | 4226 | 0.060 |
Why?
|
Sensitivity and Specificity | 4 | 2022 | 14649 | 0.050 |
Why?
|
Ethers | 1 | 2023 | 73 | 0.050 |
Why?
|
Benzothiazoles | 1 | 2024 | 247 | 0.050 |
Why?
|
Protein Binding | 4 | 2024 | 9345 | 0.050 |
Why?
|
Benzene | 1 | 2023 | 106 | 0.050 |
Why?
|
Phosphorylation | 2 | 2012 | 8311 | 0.050 |
Why?
|
Polysaccharides, Bacterial | 1 | 2006 | 578 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5671 | 0.050 |
Why?
|
Recombinant Proteins | 4 | 2021 | 6520 | 0.050 |
Why?
|
Computational Biology | 2 | 2012 | 3509 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
HEK293 Cells | 1 | 2012 | 4269 | 0.050 |
Why?
|
Erythrocytes | 1 | 2012 | 2410 | 0.050 |
Why?
|
Time Factors | 4 | 2016 | 39908 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
Swine | 4 | 2000 | 5908 | 0.050 |
Why?
|
Lung | 1 | 2021 | 9999 | 0.050 |
Why?
|
Pentamidine | 1 | 2022 | 44 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3776 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 15908 | 0.050 |
Why?
|
Carrier Proteins | 2 | 1993 | 4937 | 0.050 |
Why?
|
Plasmodium falciparum | 1 | 2012 | 1740 | 0.050 |
Why?
|
Viral Load | 2 | 2021 | 3325 | 0.050 |
Why?
|
Anticoagulants | 1 | 1998 | 4785 | 0.050 |
Why?
|
Cytokines | 1 | 2017 | 7373 | 0.050 |
Why?
|
Genes, Reporter | 1 | 2006 | 1525 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2011 | 7847 | 0.050 |
Why?
|
Polymyxins | 1 | 2021 | 17 | 0.050 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 2021 | 151 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2011 | 9586 | 0.050 |
Why?
|
Caulobacter crescentus | 1 | 2001 | 24 | 0.050 |
Why?
|
Spiro Compounds | 1 | 2021 | 68 | 0.050 |
Why?
|
Antigen-Antibody Reactions | 1 | 2021 | 340 | 0.050 |
Why?
|
Folic Acid Antagonists | 1 | 2021 | 75 | 0.050 |
Why?
|
Genetic Variation | 2 | 2017 | 6561 | 0.050 |
Why?
|
Acute Disease | 1 | 2011 | 7236 | 0.050 |
Why?
|
Amides | 1 | 2023 | 449 | 0.050 |
Why?
|
Biocatalysis | 1 | 2021 | 170 | 0.050 |
Why?
|
Protein Interaction Mapping | 1 | 2024 | 615 | 0.050 |
Why?
|
Indonesia | 1 | 2021 | 128 | 0.050 |
Why?
|
Peptides | 4 | 1992 | 4354 | 0.040 |
Why?
|
Vero Cells | 1 | 2021 | 481 | 0.040 |
Why?
|
Vietnam | 1 | 2021 | 406 | 0.040 |
Why?
|
Protein Structure, Quaternary | 1 | 2021 | 428 | 0.040 |
Why?
|
Immunoglobulin Variable Region | 1 | 2021 | 419 | 0.040 |
Why?
|
Viral Proteins | 2 | 2021 | 1799 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2021 | 398 | 0.040 |
Why?
|
Atlases as Topic | 1 | 2021 | 247 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2022 | 616 | 0.040 |
Why?
|
Female | 10 | 2022 | 392203 | 0.040 |
Why?
|
Antigen-Antibody Complex | 1 | 2021 | 509 | 0.040 |
Why?
|
Phagocytes | 1 | 2021 | 295 | 0.040 |
Why?
|
Blastula | 1 | 2018 | 15 | 0.040 |
Why?
|
Serologic Tests | 1 | 2021 | 381 | 0.040 |
Why?
|
Cholera | 1 | 2005 | 747 | 0.040 |
Why?
|
Quinoxalines | 1 | 2021 | 296 | 0.040 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2021 | 451 | 0.040 |
Why?
|
Rifampin | 1 | 2021 | 339 | 0.040 |
Why?
|
Inflammation | 2 | 2021 | 10759 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2021 | 652 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4242 | 0.040 |
Why?
|
Cell Fusion | 1 | 2018 | 294 | 0.040 |
Why?
|
Escherichia coli K12 | 1 | 2017 | 34 | 0.040 |
Why?
|
Administration, Topical | 1 | 2000 | 703 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 978 | 0.040 |
Why?
|
Cell Tracking | 1 | 2018 | 139 | 0.040 |
Why?
|
Autopsy | 1 | 2021 | 1008 | 0.040 |
Why?
|
Trans-Activators | 1 | 2007 | 2851 | 0.040 |
Why?
|
Transformation, Bacterial | 1 | 2017 | 76 | 0.040 |
Why?
|
Serine | 1 | 2021 | 830 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2021 | 650 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2021 | 2747 | 0.030 |
Why?
|
Larva | 1 | 2018 | 509 | 0.030 |
Why?
|
Coronary Circulation | 2 | 2000 | 1569 | 0.030 |
Why?
|
Amino Acids | 1 | 2023 | 1718 | 0.030 |
Why?
|
Fibroblasts | 2 | 2021 | 4140 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 3 | 1993 | 704 | 0.030 |
Why?
|
Microfluidics | 1 | 2022 | 651 | 0.030 |
Why?
|
Chronic Disease | 1 | 2011 | 9310 | 0.030 |
Why?
|
Japan | 1 | 2021 | 1372 | 0.030 |
Why?
|
Influenza A virus | 1 | 2020 | 458 | 0.030 |
Why?
|
Mechanical Phenomena | 1 | 2017 | 142 | 0.030 |
Why?
|
Mammals | 1 | 2022 | 1131 | 0.030 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 1996 | 110 | 0.030 |
Why?
|
Organ Specificity | 1 | 2021 | 1964 | 0.030 |
Why?
|
Genome, Viral | 1 | 2020 | 665 | 0.030 |
Why?
|
Coloring Agents | 1 | 2018 | 562 | 0.030 |
Why?
|
Membranes, Artificial | 1 | 2017 | 366 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2021 | 982 | 0.030 |
Why?
|
Male | 8 | 2022 | 360402 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 778 | 0.030 |
Why?
|
Random Allocation | 1 | 2000 | 2392 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 745 | 0.030 |
Why?
|
Drug Resistance, Viral | 1 | 2020 | 861 | 0.030 |
Why?
|
Fluoroscopy | 1 | 1999 | 945 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2023 | 1896 | 0.030 |
Why?
|
Hydrolysis | 2 | 1992 | 661 | 0.030 |
Why?
|
Tacrolimus Binding Proteins | 2 | 1993 | 194 | 0.030 |
Why?
|
Vasodilation | 1 | 1998 | 962 | 0.030 |
Why?
|
3T3 Cells | 1 | 1996 | 1085 | 0.030 |
Why?
|
Transfection | 2 | 1992 | 5765 | 0.030 |
Why?
|
Methotrexate | 1 | 2021 | 1716 | 0.030 |
Why?
|
Hirudins | 2 | 1992 | 179 | 0.030 |
Why?
|
Amino Acid Isomerases | 1 | 1993 | 31 | 0.030 |
Why?
|
Dengue | 1 | 2017 | 254 | 0.030 |
Why?
|
Adult | 5 | 2022 | 220995 | 0.030 |
Why?
|
Catheterization | 1 | 1999 | 1428 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2022 | 7995 | 0.030 |
Why?
|
Kinetics | 1 | 2021 | 6370 | 0.030 |
Why?
|
Aerobiosis | 1 | 2013 | 100 | 0.030 |
Why?
|
Anaerobiosis | 1 | 2013 | 139 | 0.030 |
Why?
|
Gliotoxin | 1 | 2012 | 3 | 0.030 |
Why?
|
HIV | 1 | 2020 | 1580 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1386 | 0.030 |
Why?
|
Breast | 1 | 2001 | 1963 | 0.030 |
Why?
|
Heparin | 1 | 2000 | 1632 | 0.030 |
Why?
|
Virulence Factors, Bordetella | 1 | 1992 | 154 | 0.020 |
Why?
|
Calmodulin-Binding Proteins | 1 | 1993 | 233 | 0.020 |
Why?
|
Regeneration | 1 | 2021 | 1505 | 0.020 |
Why?
|
ROC Curve | 1 | 2020 | 3575 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2019 | 1528 | 0.020 |
Why?
|
Cohort Studies | 3 | 2022 | 41464 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1992 | 416 | 0.020 |
Why?
|
HLA-A2 Antigen | 1 | 1992 | 209 | 0.020 |
Why?
|
Phosphoprotein Phosphatases | 1 | 1993 | 328 | 0.020 |
Why?
|
rab5 GTP-Binding Proteins | 1 | 2011 | 48 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2021 | 3392 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2013 | 346 | 0.020 |
Why?
|
Protein Unfolding | 1 | 2011 | 56 | 0.020 |
Why?
|
Rabbits | 1 | 1998 | 4770 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2022 | 58919 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2022 | 5239 | 0.020 |
Why?
|
Anthrax | 1 | 2011 | 83 | 0.020 |
Why?
|
Models, Molecular | 1 | 2021 | 5433 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1992 | 1058 | 0.020 |
Why?
|
Xenopus laevis | 2 | 1992 | 963 | 0.020 |
Why?
|
Heart | 2 | 2021 | 4403 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2018 | 2690 | 0.020 |
Why?
|
Cyclosporine | 1 | 1993 | 776 | 0.020 |
Why?
|
Trypsin | 1 | 2011 | 495 | 0.020 |
Why?
|
Monocytes | 1 | 2020 | 2565 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3705 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2018 | 2382 | 0.020 |
Why?
|
Disulfides | 1 | 2012 | 464 | 0.020 |
Why?
|
Gene Expression | 2 | 2021 | 7569 | 0.020 |
Why?
|
Molecular Weight | 1 | 1992 | 2185 | 0.020 |
Why?
|
Tumor Cells, Cultured | 2 | 1994 | 6126 | 0.020 |
Why?
|
rab GTP-Binding Proteins | 1 | 2011 | 250 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2013 | 730 | 0.020 |
Why?
|
Cell Lineage | 1 | 2018 | 2553 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2021 | 4533 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4345 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2021 | 3672 | 0.020 |
Why?
|
Open Reading Frames | 1 | 1992 | 813 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2013 | 1864 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3550 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2000 | 4470 | 0.020 |
Why?
|
Endopeptidases | 1 | 1992 | 774 | 0.020 |
Why?
|
Databases, Nucleic Acid | 1 | 2008 | 205 | 0.020 |
Why?
|
Cross Infection | 1 | 2017 | 1422 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2013 | 1550 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5201 | 0.020 |
Why?
|
DNA Damage | 1 | 1996 | 2445 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3794 | 0.020 |
Why?
|
Cattle | 1 | 1992 | 3841 | 0.020 |
Why?
|
Oligopeptides | 1 | 1992 | 1185 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2012 | 2231 | 0.020 |
Why?
|
Influenza Vaccines | 1 | 2013 | 767 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 2021 | 9171 | 0.020 |
Why?
|
Injections | 2 | 1999 | 832 | 0.020 |
Why?
|
Dimerization | 1 | 2007 | 890 | 0.020 |
Why?
|
Europe | 1 | 2012 | 3415 | 0.020 |
Why?
|
Sirolimus | 1 | 1992 | 1533 | 0.020 |
Why?
|
Blood Platelets | 2 | 1992 | 2478 | 0.010 |
Why?
|
Cell Division | 1 | 1992 | 4457 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9313 | 0.010 |
Why?
|
Aged | 4 | 2022 | 169092 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15829 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 1992 | 2073 | 0.010 |
Why?
|
Middle Aged | 4 | 2022 | 220603 | 0.010 |
Why?
|
Models, Genetic | 1 | 2012 | 3431 | 0.010 |
Why?
|
Young Adult | 2 | 2022 | 59191 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12661 | 0.010 |
Why?
|
Vaccination | 1 | 2013 | 3370 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 3688 | 0.010 |
Why?
|
Therapeutic Irrigation | 1 | 2001 | 289 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26065 | 0.010 |
Why?
|
Apoptosis | 1 | 1996 | 9476 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2001 | 531 | 0.010 |
Why?
|
Adolescent | 2 | 2022 | 88247 | 0.010 |
Why?
|
Xenopus | 2 | 1992 | 711 | 0.010 |
Why?
|
Algorithms | 2 | 2012 | 14024 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11874 | 0.010 |
Why?
|
Rats | 2 | 1992 | 23716 | 0.010 |
Why?
|
Drug Administration Routes | 1 | 1999 | 150 | 0.010 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 1999 | 56 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 2 | 2001 | 3730 | 0.010 |
Why?
|
Nitroprusside | 1 | 1998 | 272 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2001 | 836 | 0.010 |
Why?
|
Cytodiagnosis | 1 | 2001 | 447 | 0.010 |
Why?
|
Adenosine Diphosphate | 1 | 1998 | 422 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 1999 | 748 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 1998 | 517 | 0.010 |
Why?
|
Prospective Studies | 2 | 2017 | 54364 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2001 | 1624 | 0.010 |
Why?
|
Oocytes | 2 | 1991 | 1166 | 0.010 |
Why?
|
Endothelial Growth Factors | 1 | 1999 | 673 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1993 | 10175 | 0.010 |
Why?
|
Lymphokines | 1 | 1999 | 925 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 1998 | 908 | 0.010 |
Why?
|
Vascular Resistance | 1 | 1998 | 930 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 64572 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1999 | 2261 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1999 | 2214 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 1998 | 973 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2001 | 20988 | 0.010 |
Why?
|
Safety | 1 | 1999 | 1149 | 0.010 |
Why?
|
Peptidylprolyl Isomerase | 1 | 1993 | 97 | 0.010 |
Why?
|
Protein Sorting Signals | 1 | 1993 | 278 | 0.010 |
Why?
|
Calcineurin | 1 | 1993 | 229 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2000 | 36401 | 0.010 |
Why?
|
RNA, Complementary | 1 | 1991 | 45 | 0.010 |
Why?
|
Protein Denaturation | 1 | 1992 | 242 | 0.010 |
Why?
|
Nucleoproteins | 1 | 1992 | 113 | 0.010 |
Why?
|
Anions | 1 | 1991 | 136 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1992 | 851 | 0.010 |
Why?
|
Crystallization | 1 | 1992 | 533 | 0.010 |
Why?
|
Indicators and Reagents | 1 | 1992 | 460 | 0.010 |
Why?
|
Poly A | 1 | 1991 | 181 | 0.010 |
Why?
|
Viral Matrix Proteins | 1 | 1992 | 196 | 0.010 |
Why?
|
Microinjections | 1 | 1991 | 321 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 1992 | 1433 | 0.010 |
Why?
|
Endothelium | 1 | 1991 | 764 | 0.000 |
Why?
|
Neoplasms | 1 | 2017 | 22131 | 0.000 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 1999 | 3492 | 0.000 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1991 | 1692 | 0.000 |
Why?
|
HIV Envelope Protein gp120 | 1 | 1992 | 914 | 0.000 |
Why?
|
Megakaryocytes | 1 | 1991 | 566 | 0.000 |
Why?
|
Endothelium, Vascular | 1 | 1998 | 4433 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1992 | 6074 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1991 | 5109 | 0.000 |
Why?
|